Business Wire

New Studies Investigate the Accuracy of Noninvasive, Continuous Hemoglobin Monitoring with Masimo SpHb ® on Neonates

Noting that “iatrogenic anemia caused by diagnostic blood sampling is a common problem in intensive care units,” especially in neonatal intensive care units (NICUs), and that diagnostic blood sampling ...

Masimo: Danaher Acquisition Saves The Company From Lackluster Performance

Masimo Corporation agreed to be acquired by Danaher for $180/share, valuing MASI at $9.9B. Click here to read my most recent ...
Seeking Alpha

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
Nasdaq

Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen

Without ORi, there is no noninvasive way to monitor oxygenation under supplemental oxygen to manage hyperoxia, or higher than normal oxygenation of arterial blood. There is growing evidence that ...
Becker's Hospital Review

University Hospitals to roll out remote monitoring systemwide by 2026

Cleveland-based University Hospitals is expanding its remote patient monitoring program across its entire system. The expansion will equip 1,500 hospital beds with Masimo’s wireless Radius VSM devices ...